Masashi Akiyama
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Masashi Akiyama has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
H. Shimizu
Department of Dermatology, Teikyo University School of Medicine, Ichihara Hospital, 3426‐3 Anesaki, Ichihara, Chiba 299‐0111, Japan *Department of Dermatology, Keio University School of Medicine, Tokyo, Japan †Department of Dermatology, Kyorin University School of Medicine, Tokyo, Japan ‡Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
2 shared publicationsN. Inamoto
Division of Dermatology, Kitasato Institute Hospital, Tokyo, 108‐8642, Japan
2 shared publicationsH Shimizu
Department of Dermatology, Keio University School of Medicine, Tokyo 160‐0016, Japan
1 shared publicationHiroshi Shimizu
1 shared publicationK Hashimoto
Department of Dermatology, Ehime University School of Medicine, Ehime 791‐0295, Japan
1 shared publicationK. Hashigucci
1 shared publication
Latest Publications
- 1 March 2001
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 144 (3) , 604-609
Arteriovenous haemangioma in chronic liver disease: clinical and histopathological features of four cases
Chronic liver diseases are known to cause several skin manifestations, including cutaneous vascular changes such as spider naevus and palmar erythema. Arteriovenous haemangioma (AVH), a benign acquir...
- 1 March 2001
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 144 (3) , 604-609
Arteriovenous haemangioma in chronic liver disease: clinical and histopathological features of four cases
Chronic liver diseases are known to cause several skin manifestations, including cutaneous vascular changes such as spider naevus and palmar erythema. Arteriovenous haemangioma (AVH), a benign acquir...
- 1 February 2001
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 144 (2) , 401-407
Novel mutations of TGM1 in a child with congenital ichthyosiform erythroderma
We report novel mutations in the transglutaminase (TGase) 1 gene (TGM1) in a Japanese boy with non‐bullous congenital ichthyosiform erythroderma (NBCIE). The patient showed fine, grey or light‐brown ...
- 1 February 2001
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 144 (2) , 401-407
Novel mutations of TGM1 in a child with congenital ichthyosiform erythroderma
We report novel mutations in the transglutaminase (TGase) 1 gene (TGM1) in a Japanese boy with non‐bullous congenital ichthyosiform erythroderma (NBCIE). The patient showed fine, grey or light‐brown ...
- 1 February 2000
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 142 (2) , 223-225
Expression of transglutaminase activity in developing human epidermis
Epidermal transglutaminase (TGase) is known to catalyse cross‐linking of several precursor proteins in the formation of cornified cell envelope at the terminal differentiation of keratinocytes. Expre...
- 1 February 2000
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 142 (2) , 223-225
Expression of transglutaminase activity in developing human epidermis
Epidermal transglutaminase (TGase) is known to catalyse cross‐linking of several precursor proteins in the formation of cornified cell envelope at the terminal differentiation of keratinocytes. Expre...
- 1 February 2000
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 114 (2) , 321-327
Changing Patterns of Localization of Putative Stem Cells in Developing Human Hair Follicles
- 1 February 2000
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 114 (2) , 321-327
Changing Patterns of Localization of Putative Stem Cells in Developing Human Hair Follicles
- 1 September 1999
- Published by Wiley in British Journal of Dermatology
- Vol. 141 (3) , 447-452
Epimorphin expression during human foetal hair follicle development
Epimorphin is a mesenchymal protein expressed in several organs and known to have an essential role in epithelial tissue organization, including hair follicle morphogenesis, in mice. Although about 90% homology has been reported between human and mouse epimorphin exon sequences, there is no information about expression and function of epimorphin in hair follicle development in humans. In order to elucidate the expression pattern of epimorphin in human hair follicle morphogenesis and to compare it with the distribution of tenascin and neural cell adhesion molecule (NCAM), skin samples from human foetuses of a series of estimated gestational ages (EGAs) (46–168 days EGA) were studied using monoclonal anti‐epimorphin antibody MC‐1, anti‐tenascin antibody and anti‐human NCAM antibody. Epimorphin was detected in the mesenchymal cell condensation at the pregerm stage (< 75 days EGA), and there was strong expression of epimorphin in the perifollicular mesenchymal cells around the hair germ (75–84 days EGA). At the hair peg stage (85–104 days EGA), epimorphin was around the hair peg with the strongest staining in the neck portion. This sequence of staining patterns was similar to that of tenascin. In the bulbous hair peg (105–134 days EGA), the perifollicular dermal mesenchymal cells were evenly positive for epimorphin. Mesenchymal cells underneath the follicle bulb prior to formation of the dermal papilla were also positive for epimorphin. In the lanugo hair follicle (> 134 days EGA), dermal papilla cells expressed epimorphin as well as tenascin and NCAM. These results indicate that epimorphin expression is closely linked to developing hair follicles in human foetuses. This suggests that epimorphin may have an important part in induction of morphogenesis during human foetal hair follicle development.
- 1 September 1999
- Published by Wiley in British Journal of Dermatology
- Vol. 141 (3) , 447-452
Epimorphin expression during human foetal hair follicle development
Epimorphin is a mesenchymal protein expressed in several organs and known to have an essential role in epithelial tissue organization, including hair follicle morphogenesis, in mice. Although about 90% homology has been reported between human and mouse epimorphin exon sequences, there is no information about expression and function of epimorphin in hair follicle development in humans. In order to elucidate the expression pattern of epimorphin in human hair follicle morphogenesis and to compare it with the distribution of tenascin and neural cell adhesion molecule (NCAM), skin samples from human foetuses of a series of estimated gestational ages (EGAs) (46–168 days EGA) were studied using monoclonal anti‐epimorphin antibody MC‐1, anti‐tenascin antibody and anti‐human NCAM antibody. Epimorphin was detected in the mesenchymal cell condensation at the pregerm stage (< 75 days EGA), and there was strong expression of epimorphin in the perifollicular mesenchymal cells around the hair germ (75–84 days EGA). At the hair peg stage (85–104 days EGA), epimorphin was around the hair peg with the strongest staining in the neck portion. This sequence of staining patterns was similar to that of tenascin. In the bulbous hair peg (105–134 days EGA), the perifollicular dermal mesenchymal cells were evenly positive for epimorphin. Mesenchymal cells underneath the follicle bulb prior to formation of the dermal papilla were also positive for epimorphin. In the lanugo hair follicle (> 134 days EGA), dermal papilla cells expressed epimorphin as well as tenascin and NCAM. These results indicate that epimorphin expression is closely linked to developing hair follicles in human foetuses. This suggests that epimorphin may have an important part in induction of morphogenesis during human foetal hair follicle development.
- 1 July 1999
- Published by S. Karger AG in Dermatology
- Vol. 199 (3) , 263-264
Frontal Mucocele Presenting as a Subcutaneous Tumour on the Forehead
A 57-year-old Japanese woman had a 3-month history of an asymptomatic subcutaneous tumour on the forehead. The patient presented a slightly elevated, elastic soft subcutaneous mass, 3 cm in diameter, on the mid to left-side forehead. Slight swelling of the left upper eyelid was observed. CT scanning and magnetic resonance images revealed a sharply demarcated cystic mass from the subcutaneous area on the forehead expanding into the frontal sinus and intracranial space. The tumour was diagnosed as a frontal mucocele and combined external and endoscopic approaches were performed. It is rare that a patient with a frontal mucocele is initially referred as a case of a subcutaneous tumour because most of the patients complain primarily of the ophthalmic symptoms. However, the present case reminds us that frontal mucocele is one of the differential diagnoses for a subcutaneous mass on the forehead.
- 1 July 1999
- Published by S. Karger AG in Dermatology
- Vol. 199 (3) , 263-264
Frontal Mucocele Presenting as a Subcutaneous Tumour on the Forehead
A 57-year-old Japanese woman had a 3-month history of an asymptomatic subcutaneous tumour on the forehead. The patient presented a slightly elevated, elastic soft subcutaneous mass, 3 cm in diameter, on the mid to left-side forehead. Slight swelling of the left upper eyelid was observed. CT scanning and magnetic resonance images revealed a sharply demarcated cystic mass from the subcutaneous area on the forehead expanding into the frontal sinus and intracranial space. The tumour was diagnosed as a frontal mucocele and combined external and endoscopic approaches were performed. It is rare that a patient with a frontal mucocele is initially referred as a case of a subcutaneous tumour because most of the patients complain primarily of the ophthalmic symptoms. However, the present case reminds us that frontal mucocele is one of the differential diagnoses for a subcutaneous mass on the forehead.